InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Chan Thomas (TC), Chief Financial Officer. Director active across 1 company, notably GoodRx Holdings, Inc.. In total, 11 disclosures have been recorded. Activity tracked since 15 May 2026. The latest transaction was filed on 15 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
1,969 sharesClass A Common StockSEC:0001809519-26-000120:0
1,002 sharesClass A Common StockSEC:0001809519-26-000120:1
2,100 sharesClass A Common StockSEC:0001809519-26-000120:2
1,069 sharesClass A Common StockSEC:0001809519-26-000120:3
638 shares@ US$2.490.0001% mcap22.5% of flowClass A Common StockSEC:0001809519-26-000115:1
2,637 sharesClass A Common StockSEC:0001809519-26-000115:2
1,342 shares@ US$2.490.0003% mcap47.3% of flowClass A Common StockSEC:0001809519-26-000115:3
1,686 sharesClass A Common StockSEC:0001809519-26-000115:4
858 shares@ US$2.490.0002% mcap30.2% of flowClass A Common StockSEC:0001809519-26-000115:5
1,252 sharesClass A Common StockSEC:0001809519-26-000115
1,252 sharesClass A Common StockSEC:0001809519-26-000115:0
11 of 11 declarations
About Chan Thomas (TC)
Thomas Chan is the Chief Accounting Officer at GoodRx Holdings, Inc. He oversees the accounting and financial operations of the company, ensuring compliance and integrity in financial reporting. His role is essential for GoodRx's financial strategy.
